Barbara Ann Karmanos Cancer Institute

Michigan Center, Michigan 48201

0 studies enrolling now · 1 studies all time

What they study most

Advanced Refractory Solid Tumors, Subjects Considered Likely to Respond to CB-03-10

Studies at this site

• Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors — Status unconfirmed